VERV logo

Verve Therapeutics, Inc. (VERV)

Profile

Full Name

Verve Therapeutics, Inc.

Ticker

NASDAQ: VERV

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 17, 2021

Indexes

Not included

Website

https://www.vervetx.com

Employees

274

Key Details

Price

$11.13

Market cap

$992.16M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$32.33M(+174.98% YoY)

Annual EPS

-$2.35(+24.68% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $11.13
    VERV price is $11.13

    30-Day Relative Volume

    0.00
    VERV 30-day relative volume is 0.00

    Price Performance

    Price Most recent change

    -
    VERV price change on Jul 24, 2025 is unknown

    Price YTD change

    +97.34%
    VERV price is up +97.34% since January 1st

    Price 1-year change

    +145.15%
    VERV price is up +145.15% year-on-year

    Price 3-year change

    -70.6%
    VERV price is down -70.6% over the past 3 years

    Price Range

    Price All-time high

    $78.00
    VERV price is currently -85.73% below its historical high of $78.00

    Price 3-year low

    $2.87
    VERV price is currently +288.48% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $992.16M
    VERV market capitalization is $992.16 million

    Market cap 3-year change

    -55.57%
    VERV market capitalization is down -55.57% over the past 3 years

    Market cap All-time high

    $3.55B
    VERV market capitalization is currently -72.06% below its historical high of $3.55 billion

    Market cap sector rank

    -
    VERV market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +5.34%
    VERV shares outstanding is up +5.34% year-on-year

    Shares Outstanding 3-Year Change

    +48.72%
    VERV shares outstanding is up +48.72% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.40
    VERV beta is 1.40

    200-day SMA

    $6.45
    VERV price is currently +72.51% above its 200-day simple moving average

    50-day SMA

    $8.21
    VERV price is currently +35.51% above its 50-day simple moving average

    RSI

    76.26
    VERV 14-day relative strength index is 76.26

    Volume

    0.00
    VERV 30-day relative volume is 0.00

    ATR

    $0.20
    VERV average true range is $0.20

    10-day Historical Volatility

    8.54%
    VERV 10-day historical volatility is 8.54%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $32.33M
    VERV annual revenue is $32.33 million

    Revenue Analysts estimate

    $45.04M
    VERV annual revenue is currently -28.22% lower than the consensus analysts' forecast

    Revenue 1-year change

    +174.98%
    VERV annual revenue is up +174.98% year-on-year

    Revenue Sector rank

    -
    VERV annual revenue is unknown

    EPS

    EPS

    -$2.35
    VERV annual earnings per share is -$2.35

    EPS Analysts estimate

    -$2.53
    VERV annual earnings per share is currently -7.06% lower than the consensus analysts' forecast

    EPS 1-year change

    +24.68%
    VERV annual earnings per share is up +24.68% year-on-year

    EPS Sector rank

    -
    VERV annual earnings per share is unknown

    Profit

    Gross profit

    -
    VERV annual gross profit value is unknown

    Gross margin

    -
    VERV annual gross profit margin value is unknown

    Operating profit

    -$228.66M
    VERV annual operating income is -$228.66 million

    Operating margin

    -707.23%
    VERV annual operating profit margin is -707.23%

    Net income

    -$198.71M
    VERV annual net profit is -$198.71 million

    Net margin

    -614.59%
    VERV annual net profit margin is -614.59%

    Expenses

    Total expenses

    $260.99M
    VERV annual total expenses is $260.99 million

    Operating expenses

    $260.99M
    VERV annual total operating expenses is $260.99 million

    Cost of goods sold

    -
    VERV annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $56.65M
    VERV annual SGA is $56.65 million

    Depreciation and amortization

    $6.75M
    VERV annual depreciation & amortization is $6.75 million

    Interest expense

    -
    VERV annual interest expense value is unknown

    Income tax

    $349.00K
    VERV annual income tax is $349.00 thousand

    EBIT & EBITDA

    EBIT

    -$228.66M
    VERV annual earnings before interest & taxes is -$228.66 million

    EBITDA

    -$221.91M
    VERV annual EBITDA is -$221.91 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $647.39M
    VERV annual total assets is $647.39 million

    Non current assets

    $104.64M
    VERV annual long term assets is $104.64 million

    Current assets

    $542.75M
    VERV annual total current assets is $542.75 million

    Cash and cash equivalents

    $172.56M
    VERV annual cash & cash equivalents is $172.56 million

    Accounts receivable

    -
    VERV annual accounts receivable value is unknown

    Inventory

    -
    VERV annual inventory value is unknown

    Liabilities

    Total liabilities

    $153.99M
    VERV annual total liabilities is $153.99 million

    Long term liabilities

    $111.08M
    VERV annual total long term liabilities is $111.08 million

    Current liabilities

    $42.91M
    VERV annual total current liabilities is $42.91 million

    Accounts payable

    $4.52M
    VERV annual accounts payable is $4.52 million

    Debt

    Total debt

    $69.98M
    VERV annual total debt is $69.98 million

    Total debt 1-year change

    -6.57%
    VERV annual total debt is down -6.57% year-on-year

    Long term debt

    $59.54M
    VERV annual long term debt is $59.54 million

    Short term debt

    $10.44M
    VERV annual short term debt is $10.44 million

    Equity & Capital

    Shareholders equity

    $493.40M
    VERV annual stockholders equity is $493.40 million

    Book value

    $493.40M
    VERV annual book value is $493.40 million

    Retained earnings

    -$743.01M
    VERV annual retained earnings is -$743.01 million

    Working capital

    $499.84M
    VERV annual working capital is $499.84 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$157.69M
    VERV annual cash flow from operations is -$157.69 million

    Cash from operations 1-year change

    -5.45%
    VERV annual cash flow from operations is down -5.45% year-on-year

    Cash from investing

    $74.88M
    VERV annual cash flow from investing activities is $74.88 million

    Cash from investing 1-year change

    +170.41%
    VERV annual cash flow from investing activities is up +170.41% year-on-year

    Cash from financing

    $49.20M
    VERV annual cash flow from financing activities is $49.20 million

    Cash from financing 1-year change

    -76.86%
    VERV annual cash flow from financing activities is down -76.86% year-on-year

    CAPEX

    CAPEX

    $3.74M
    VERV annual capital expenditures is $3.74 million

    CAPEX 1-year change

    -59.75%
    VERV annual capital expenditures is down -59.75% year-on-year

    Free Cash Flow

    Free cash flow

    -$161.43M
    VERV annual free cash flow is -$161.43 million

    Free cash flow 1-year change

    -1.63%
    VERV annual free cash flow is down -1.63% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    VERV annual gross profit margin value is unknown

    Operating margin

    -707.23%
    VERV annual operating profit margin is -707.23%

    Net margin

    -614.59%
    VERV annual net profit margin is -614.59%

    ROA & ROE

    ROA

    -28.39%
    VERV annual return on assets is -28.39%

    ROE

    -36.36%
    VERV annual return on equity is -36.36%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    VERV price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    VERV price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.10
    VERV price to book ratio is 2.10

    PB ratio Sector rank

    -
    VERV price to book ratio is unknown

    PS Ratio

    PS ratio

    16.64
    VERV price to sales ratio is 16.64

    PS ratio Sector rank

    -
    VERV price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $964.25M
    VERV enterprise value is $964.25 million

    Enterprise value Sector rank

    -
    VERV enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -4.78
    VERV EV/EBITDA is -4.78

    EV/EBITDA Sector rank

    -
    VERV EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    12.65
    VERV annual current ratio is 12.65

    Quick ratio

    -
    VERV annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    VERV annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    VERV annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    VERV piotroski f-score value is unknown

    Altman Z-Score

    2.07
    VERV altman z-score is 2.07

    Analyst ratings

    Recent major analysts updates

    Jun 27, 25 BMO Capital
    Market Perform
    Jun 18, 25 LifeSci Capital
    Market Perform
    Jun 18, 25 Jefferies
    Hold
    Jun 18, 25 HC Wainwright & Co.
    Neutral
    Jun 17, 25 William Blair
    Market Perform
    Jun 17, 25 Canaccord Genuity
    Hold
    Apr 15, 25 William Blair
    Outperform
    Apr 15, 25 Guggenheim
    Buy
    Apr 15, 25 Cantor Fitzgerald
    Overweight
    Apr 15, 25 Canaccord Genuity
    Buy

    Institutional Ownership

    Screeners with VERV included

    Stocks above SMA 50
    • What is the ticker symbol for Verve Therapeutics, Inc.?
    • Does Verve Therapeutics, Inc. pay dividends?
    • What sector is Verve Therapeutics, Inc. in?
    • What industry is Verve Therapeutics, Inc. in?
    • What country is Verve Therapeutics, Inc. based in?
    • When did Verve Therapeutics, Inc. go public?
    • Is Verve Therapeutics, Inc. in the S&P 500?
    • Is Verve Therapeutics, Inc. in the NASDAQ 100?
    • Is Verve Therapeutics, Inc. in the Dow Jones?
    • When was Verve Therapeutics, Inc.'s last earnings report?
    • When does Verve Therapeutics, Inc. report earnings?

    What is the ticker symbol for Verve Therapeutics, Inc.?

    The ticker symbol for Verve Therapeutics, Inc. is NASDAQ:VERV

    Does Verve Therapeutics, Inc. pay dividends?

    No, Verve Therapeutics, Inc. does not pay dividends

    What sector is Verve Therapeutics, Inc. in?

    Verve Therapeutics, Inc. is in the Healthcare sector

    What industry is Verve Therapeutics, Inc. in?

    Verve Therapeutics, Inc. is in the Biotechnology industry

    What country is Verve Therapeutics, Inc. based in?

    Verve Therapeutics, Inc. is headquartered in United States

    When did Verve Therapeutics, Inc. go public?

    Verve Therapeutics, Inc.'s initial public offering (IPO) was on June 17, 2021

    Is Verve Therapeutics, Inc. in the S&P 500?

    No, Verve Therapeutics, Inc. is not included in the S&P 500 index

    Is Verve Therapeutics, Inc. in the NASDAQ 100?

    No, Verve Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Verve Therapeutics, Inc. in the Dow Jones?

    No, Verve Therapeutics, Inc. is not included in the Dow Jones index

    When was Verve Therapeutics, Inc.'s last earnings report?

    Verve Therapeutics, Inc.'s most recent earnings report was on August 8, 2025

    When does Verve Therapeutics, Inc. report earnings?

    The date for Verve Therapeutics, Inc.'s next earnings report has not been announced yet
    On this page